StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica r&d expenses

Research and development expenses are spending on new products and technology.

Zomedica's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.65M, down 26.9% year over year. For fiscal 2025 it was $7.17M, down 1.4% from the year before. The highest annual figure on record is $10.35M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.17M-1.4%
FY2024Dec 31, 2024$7.27M+26.5%
FY2023Dec 31, 2023$5.74M+122.8%
FY2022Dec 31, 2022$2.58M+54.1%
FY2021Dec 31, 2021$1.67M-79.2%
FY2020Dec 31, 2020$8.04M-22.2%
FY2019Dec 31, 2019$10.35M+0.3%
FY2018Dec 31, 2018$10.32M+275.0%
FY2017Dec 31, 2017$2.75M+81.2%
FY2016Dec 31, 2016$1.52M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.07M-43.3%
Q1 FY2026Mar 31, 2026$1.15M-37.7%
Q4 FY2025Dec 31, 2025$1.64M-23.4%
Q3 FY2025Sep 30, 2025$1.78M-3.3%
Q2 FY2025Jun 30, 2025$1.89M+25.2%
Q1 FY2025Mar 31, 2025$1.85M+4.6%
Q4 FY2024Dec 31, 2024$2.15M-30.8%
Q3 FY2024Sep 30, 2024$1.85M+112.8%
Q2 FY2024Jun 30, 2024$1.51M+75.3%
Q1 FY2024Mar 31, 2024$1.77M+92.9%
Q4 FY2023Dec 31, 2023$3.10M+347.2%
Q3 FY2023Sep 30, 2023$867.00K-28.6%
Q2 FY2023Jun 30, 2023$859.00K+169.3%
Q1 FY2023Mar 31, 2023$918.00K+161.5%
Q4 FY2022Dec 31, 2022$693.00K+4.2%
Q3 FY2022Sep 30, 2022$1.22M+320.4%
Q2 FY2022Jun 30, 2022$319.00K+17.7%
Q1 FY2022Mar 31, 2022$351.00K-14.8%
Q4 FY2021Dec 31, 2021$665.00K-20.7%
Q3 FY2021Sep 30, 2021$289.00K-89.3%
Q2 FY2021Jun 30, 2021$271.00K-93.1%
Q1 FY2021Mar 31, 2021$412.00K-34.6%
Q4 FY2020Dec 31, 2020$838.22K+6.1%
Q3 FY2020Sep 30, 2020$2.70M+180.7%
Q2 FY2020Jun 30, 2020$3.91M+268.2%
Q1 FY2020Mar 31, 2020$630.07K-91.6%
Q4 FY2019Dec 31, 2019$789.95K-87.9%
Q3 FY2019Sep 30, 2019$962.46K+52.7%
Q2 FY2019Jun 30, 2019$1.06M-58.1%
Q1 FY2019Mar 31, 2019$7.53M+1154.5%
Q4 FY2018Dec 31, 2018$6.55M+462.3%
Q3 FY2018Sep 30, 2018$630.37K+35.4%
Q2 FY2018Jun 30, 2018$2.53M+402.7%
Q1 FY2018Mar 31, 2018$600.34K-2.6%
Q4 FY2017Dec 31, 2017$1.17M–
Q3 FY2017Sep 30, 2017$465.50K–
Q2 FY2017Jun 30, 2017$504.24K–
Q1 FY2017Mar 31, 2017$616.45K–

More Zomedica figures

See a number that looks wrong?